Your browser doesn't support javascript.
loading
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC).
Hecht, J Randolph; Papadopoulos, Kyriakos P; Falchook, Gerald S; Patel, Manish R; Infante, Jeffrey R; Aljumaily, Raid; Wong, Deborah J; Autio, Karen A; Wainberg, Zev A; Bauer, Todd M; Javle, Milind; Pant, Shubham; Bendell, Johanna; Hung, Annie; Ratti, Navneet; VanVlasselaer, Peter; Verma, Rakesh; Leveque, Joseph; Rao, Sujata; Oft, Martin; Naing, Aung.
Afiliação
  • Hecht JR; David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Santa Monica, CA, USA. jrhecht@mednet.ucla.edu.
  • Papadopoulos KP; START Center for Cancer Care, 4383 Medical Drive, San Antonio, TX, USA.
  • Falchook GS; Sarah Cannon Research Institute at HealthONE, 1800 N Williams Street Suite 300, Denver, CO, USA.
  • Patel MR; Sarah Cannon Research Institute/Florida Cancer Specialists, 600 N Cattlemen Road Suite 200, Sarasota, FL, USA.
  • Infante JR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 300 20th Avenue N, Nashville, TN, USA.
  • Aljumaily R; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 300 20th Avenue N, Nashville, TN, USA.
  • Wong DJ; Stephenson Cancer Center of the University of Oklahoma, 800 NE 10th, Oklahoma City, OK, USA.
  • Autio KA; David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Santa Monica, CA, USA.
  • Wainberg ZA; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA.
  • Bauer TM; David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Santa Monica, CA, USA.
  • Javle M; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 300 20th Avenue N, Nashville, TN, USA.
  • Pant S; MD Anderson Cancer Center, 1515 Holcombe, Houston, TX, USA.
  • Bendell J; Stephenson Cancer Center of the University of Oklahoma, 800 NE 10th, Oklahoma City, OK, USA.
  • Hung A; MD Anderson Cancer Center, 1515 Holcombe, Houston, TX, USA.
  • Ratti N; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 300 20th Avenue N, Nashville, TN, USA.
  • VanVlasselaer P; Eli Lilly and Company, Indianapolis, IN, USA.
  • Verma R; ARMO BioSciences, a wholly owned subsidiary of Eli Lilly and Company, 575 Chesapeake Dr., Redwood City, CA, USA.
  • Leveque J; ARMO BioSciences, a wholly owned subsidiary of Eli Lilly and Company, 575 Chesapeake Dr., Redwood City, CA, USA.
  • Rao S; ARMO BioSciences, a wholly owned subsidiary of Eli Lilly and Company, 575 Chesapeake Dr., Redwood City, CA, USA.
  • Oft M; David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Santa Monica, CA, USA.
  • Naing A; Eli Lilly and Company, Indianapolis, IN, USA.
Invest New Drugs ; 39(1): 182-192, 2021 02.
Article em En | MEDLINE | ID: mdl-32910338
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Polietilenoglicóis / Protocolos de Quimioterapia Combinada Antineoplásica / Interleucina-10 / Carcinoma Ductal Pancreático Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Polietilenoglicóis / Protocolos de Quimioterapia Combinada Antineoplásica / Interleucina-10 / Carcinoma Ductal Pancreático Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos